Azathioprine
Azacitidine
Molecular Structure
Immunosuppressive Agents
Sulfur Compounds
Spiro Compounds
Volatile Organic Compounds
6-Mercaptopurine
Structure-Activity Relationship
Small Molecule Libraries
Dose-Response Relationship, Drug
Plant Extracts
Benzamidines
Drug Evaluation, Preclinical
Furans
Methyltransferases
Magnetic Resonance Spectroscopy
Heterocyclic Compounds
Inhibitory Concentration 50
Marine Toxins
Organotin Compounds
Cyclosporine
Chromatography, High Pressure Liquid
DNA Methylation
Enzyme Inhibitors
Stereoisomerism
Drug Design
Organometallic Compounds
Organoselenium Compounds
Drug Screening Assays, Antitumor
Organophosphorus Compounds
Myelodysplastic Syndromes
Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae. (1/758)
Two hundred representative isolates, including 26 strains of Streptococcus pneumoniae with intermediate resistance to penicillin, were selected from a collection obtained from blood cultures of patients with bacteraemic pneumococcal pneumonia. The MICs of moxifloxacin (BAY 12-8039), grepafloxacin, sparfloxacin, levofloxacin, ofloxacin, ciprofloxacin, erythromycin, tetracycline and penicillin G were determined by a standard agar dilution technique. Moxifloxacin had the highest in-vitro activity against S. pneumoniae (MIC90 = 0.25 mg/L; MIC range 0.06-0.25 mg/L). The MIC90 values were one dilution lower than those obtained with sparfloxacin and grepafloxacin, three dilutions lower than those obtained with levofloxacin, and four dilutions lower than those of ofloxacin and ciprofloxacin. (+info)The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. (2/758)
In Staphylococcus aureus, in addition to mutations in the grl and gyr gene loci, multidrug efflux pumps like NorA contribute to decreased fluoroquinolone susceptibility. Efflux pumps can be inhibited by the plant alkaloid reserpine, which, at 20 mg/L, reduced sparfloxacin, moxifloxacin and ciprofloxacin IC50s and MICs by up to four-fold in 11, 21 and 48 of the 102 unrelated clinical isolates tested, respectively. The effect was less pronounced with the hydrophobic drugs sparfloxacin and moxifloxacin than with the hydrophilic drug ciprofloxacin and was stable in all 25 clonally related isolates tested. (+info)Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration. (3/758)
A single 400-mg oral or intravenous (i.v.) dose of moxifloxacin was given to each of eight healthy male volunteers, and 6 weeks later the dose was administered by the other route. The concentrations of the drug in plasma, cantharidin-induced inflammatory fluid, and urine were measured over the subsequent 24 h. The mean maximum concentrations observed in plasma were 4.98 microg/ml after oral dosing and 5.09 microg/ml after i.v. dosing. The mean maximum concentrations attained in the inflammatory fluid were 2.62 and 3.23 microg/ml, respectively. The mean elimination half-lives from plasma were 8.32 and 8.17 h, respectively. The overall penetration into the inflammatory fluid was 103.4 and 104.2%. Over 24 h 15% of the drug was recovered in the urine when administered by either route. (+info)Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. (4/758)
The antistaphylococcal activities of four newly developed antibiotics, moxifloxacin (an 8-methoxyfluoroquinolone), trovafloxacin (a naphthyridone), quinupristin/dalfopristin (a semisynthetic streptogramin) and linezolid (an oxazolidinone), were examined and compared with those of ciprofloxacin, vancomycin and teicoplanin, using an agar dilution method. A total of 245 clinical isolates of staphylococci, including a large number of clonally different methicillin-resistant strains, were tested. The new agents tested exhibited wide-spectrum antistaphylococcal activity against both methicillin-susceptible and methicillin-resistant strains. In contrast to the quinolones, the in-vitro activities of quinupristin/dalfopristin, linezolid and the glycopeptides remained almost unchanged, irrespective of the resistance phenotype for methicillin. A number of isolates with elevated quinolone MICs were observed. (+info)Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network. (5/758)
Antibiotic resistance among Streptococcus pneumoniae isolates has spread rapidly throughout the world since the first description of a strain with diminished susceptibility to penicillin in Australia in 1967. A total of 1385 strains of S. pneumoniae, collected in several centres throughout Austria, were assessed for their sensitivity to moxifloxacin, trovafloxacin, ciprofloxacin, ofloxacin, levofloxacin and lomefloxacin. The MICs were determined using the agar dilution method, according to NCCLS guidelines. Both moxlfloxacin and trovafloxacin showed good anti-pneumococcal activity in terms of MIC50 (both 0.125 mg/L) and MIC90 (both 0.25 mg/L). Less active, but with similar activity to each other, were ciprofloxacin and levofloxacin, each with an MIC50 of 1 mg/L and an MIC90 of 2 mg/L. Ofloxacin showed only moderate activity (MIC50, 1 mg/L; MIC90, 2 mg/L) and lomefloxacin was the least active compound (MIC50, 4 mg/L; MIC90, 8 mg/L). Both moxifloxacin and trovafloxacin at a concentration of < or = 0.5 mg/L inhibited all of the S. pneumoniae strains tested. (+info)In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis. (6/758)
MICs of the new fluoroquinolone, moxifloxacin, and those of ciprofloxacin, ofloxacin and sparfloxacin for 19 genetically characterized fluoroquinolone-resistant strains were determined by the agar dilution method. The MICs of moxifloxacin for Escherichia isolates with one mutation in gyrA (corresponding to Ser83-->Leu or Asp87-->Gly substitution) were 0.25-0.5 mg/L, while those of ciprofloxacin, ofloxacin and sparfloxacin were 0.06-0.25, 1 and 0.12-0.5 mg/L, respectively. These values were four- to 16-fold higher than those of the same antibiotics for the wild-type strain, E. coli KL16. Similar results were observed with clinical isolates of Salmonella spp. harbouring one mutation in gyrA leading to the substitution of Ser83 by Phe or Tyr. In the presence of two mutations in the E. coli gyrA gene, the MICs of moxifloxacin ciprofloxacin, ofloxacin and sparfloxacin were 2, 0.5, 4 and 1 mg/L, respectively; these were 32 times higher than the MICs of these agents for E. coli KL16. The MICs of the four quinolones for triple mutants with two mutations in gyrA and one in parC were even higher, i.e. 8, 8, 16 and 8-16 mg/L, respectively. The MICs of moxifloxacin for Campylobacter coli and Campylobacter jejuni strains with a gyrA mutation leading to Thr86-->Ile substitution ranged from 1 to 2 mg/L, while the MICs of ciprofloxacin, ofloxacin and sparfloxacin were 16-32 mg/L, 8-16 and 4-8 mg/L, respectively. For high-level ciprofloxacin-resistant (MICs of 32 mg/L) clinical isolates of Enterococcus faecalis with one substitution at position 83 in GyrA (E. coli coordinates), the MICs of moxifloxacin, ofloxacin and sparfloxacin were 8-16, > or = 128 and 32 mg/L respectively. In conclusion, moxifloxacin and other fluoroquinolones exhibit cross-resistance against aerobic gram-negative bacilli and enterococci. The in-vitro activity of moxifloxacin was greater than that of ofloxacin and slightly less than that of ciprofloxacin and sparfloxacin against Enterobacteriaceae, but greater than those of the three other compounds tested against Campylobacter spp and E. faecalis. (+info)The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. (7/758)
The in-vitro activities of moxifloxacin, ciprofloxacin, erythromycin and rifampicin against 49 Legionella spp. isolates were determined by an agar dilution method with buffered charcoal yeast extract agar containing alpha-ketoglutarate. Because the inhibitory effects of charcoal in the test media were pronounced (92% for quinolones, 90.5% for rifampicin and 92.5% for erythromycin), the MICs were corrected for the charcoal-bound fraction of the antibiotics. The corrected geometric mean MICs were 0.018 mg/L for moxifloxacin, 0.02 mg/L for ciprofloxacin, 0.27 mg/L for erythromycin and 0.005 mg/L for rifampicin. (+info)The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus. (8/758)
The effect of moxifloxacin on its target enzymes was evaluated by three different approaches: (i) the MICs of moxifloxacin and nine other fluoroquinolones were determined for mutants of Escherichia coli (n = 13) and Staphylococcus aureus (n = 5) carrying different combinations of resistance mutations; (ii) the activity of moxifloxacin on isolated targets was determined as IC50 values for wild-type and mutant type II topoisomerases from E. coli; and (iii) the mutation frequencies were determined for two single-step mutants (MI with a Ser83-->Leu mutation in gyrA and WT-4 with a Ser80-->Ile mutation in parC) and their parent strain (WT). Of the quinolones tested, moxifloxacin was the only one showing an equivalent high activity against both targets. This is reflected by a comparable high susceptibility of the test strains of E. coli and S. aureus and by the IC50 values of moxifloxacin which were 50-90% lower than those of ciprofloxacin, norfloxacin and sparfloxacin for the wild-type and single mutant enzymes of gyrase and topoisomerase IV. However, double mutant GyrA was significantly more sensitive to moxifloxacin than to the other fluoroquinolones tested, while wild-type topoisomerase IV was two-fold more refractory. Mutation rates of WT, MI and WT-4 for ciprofloxacin and moxifloxacin were 5 x 10(-8) vs 4 x 10(-10); <6 x 10(-11) vs <6 x 10(-11); and 2 x 10(-6) vs 5 x 10(-7), respectively. These data indicate an equivalent high inhibitory activity of moxifloxacin on DNA gyrase and topoisomerase IV of E. coli. (+info)There are several subtypes of MDS, each with distinct clinical features and prognosis. The most common subtype is refractory anemia with excess blasts (RAEB), followed by chronic myelomonocytic leukemia (CMMoL) and acute myeloid leukemia (AML).
The exact cause of MDS is not fully understood, but it is believed to result from a combination of genetic mutations and environmental factors. Risk factors for developing MDS include exposure to certain chemicals or radiation, age over 60, and a history of previous cancer treatment.
Symptoms of MDS can vary depending on the specific subtype and severity of the disorder, but may include fatigue, weakness, shortness of breath, infection, bleeding, and easy bruising. Diagnosis is typically made through a combination of physical examination, medical history, blood tests, and bone marrow biopsy.
Treatment for MDS depends on the specific subtype and severity of the disorder, as well as the patient's overall health and preferences. Options may include supportive care, such as blood transfusions and antibiotics, or more intensive therapies like chemotherapy, bone marrow transplantation, or gene therapy.
Overall, myelodysplastic syndromes are a complex and heterogeneous group of disorders that can have a significant impact on quality of life and survival. Ongoing research is focused on improving diagnostic accuracy, developing more effective treatments, and exploring novel therapeutic approaches to improve outcomes for patients with MDS.
List of phenyltropanes
Progesterone 3-oxime
Azelaic acid
Polysilazane
Imine
Diels-Alder reaction
Fenestrane
Aza-crown ether
Azadirachtin
Azakhel Payan
Organic azide
Hydrogen-bond catalysis
Boraacenes
Aza-
Diethyl azodicarboxylate
Aza-Cope rearrangement
Tetrahedral carbonyl addition compound
Inverse electron-demand Diels-Alder reaction
Cyclam
5-Aza-7-deazapurine
5-Aza-7-deazaguanine
Stannatrane
12-Crown-4
Fresno Chaffee Zoo
Baylis
Azaborane
Dioscorine
Strictosidine synthase
Diisopropyl azodicarboxylate
Deoxycytidine
6-Amino-5-nitropyridin-2-one
GABAA receptor positive allosteric modulator
Intramolecular reaction
Polyene
Ionic liquid
Epigenetic therapy
Bioorthogonal chemistry
Pharmacoepigenetics
Povarov reaction
Kirsanov reaction
Aza-Baylis-Hillman reaction
Epigenetics of neurodegenerative diseases
Aptazapine
List of California Institute of Technology people
Stieglitz rearrangement
Aquarium
FCE 28260
Crown ether
Candocuronium iodide
Canadian Reference Materials
L-selectride
Via Crucis to the Cruz del Campo
Atrane
Finasteride
Tulsa Zoo
Quinoline
Enantioselective synthesis
Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone
STRUCTURAL STUDIES OF ORGANOBORON COMPOUNDS .19. 1,7-DIMETHYL-3,5-DIPHENYL-2,4,6-TRIOXA-7-AZA-1-AZONIA-3-BORA-5-BORATABIC YCLO...
New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr - PubMed
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy - PubMed
Publication Detail
Biomarkers Search
MeSH Browser
NIH Common Fund
DeCS
MeSH Browser
13R,14S,18R,19S)-9,19-dihydroxy-16-oxido-16-oxo-5,7,15,17-tetraoxa-12-aza-16lambda5-phosphapentacyclo[11.7.0.02,10.04,8.014,18...
will vanacof make you pop hot on a drug test - lookformedical.com
RFA-CA-03-016: DIET, DNA METHYLATION AND OTHER EPIGENETIC EVENTS, AND CANCER PREVENTION
Synthesis and Spectroscopic Investigation of a Hexaaza Lanthanum(III) Macrocycle with a Hybrid-Type G4 DNA Stabilizing Effect
RU2747292C1 - Method for activating germination of sugar beet seeds - Google Patents
PAR-02-175: DIET, DNA METHYLATION AND OTHER EPIGENETIC EVENTS, AND CANCER PREVENTION:
COMPETING SUPPLEMENTS
Pesquisa | Portal Regional da BVS
NDF-RT Code NDF-RT Name
NIOSHTIC-2 Search Results - Full View
Crown Compounds | Profiles RNS
Other Pharmacology mentored projects (9)
Division of AIDS Anti-HIV/OI/TB Therapeutics Database - Surveillance Memo
Ag-SiO2 Nanoparticles: Benign, Expedient, and Facile Nano Catalyst in Synthesis of Decahydroacridines
DailyMed - PIMECROLIMUS cream
Apalutamide | HIF signal
Efficient Synthesis of Bis(3-Methylphenyl)Sulfoxide Aza Macrocycles from a Bis(3-Methylphenyl)Sulfoxide Diester and Diamine...
NIH Common Fund
Volatile Organic C1
- Capillary chromatographic analysis of volatile organic compounds in the indoor environment. (cdc.gov)
Organic compounds4
- Industrial hygiene surveys were conducted, and air samples were collected for analysis of polynuclear aromatic hydrocarbons, polynuclear aza heterocyclic hydrocarbons, aromatic amines, metals, common toxic gases, and other organic compounds. (cdc.gov)
- Kinetics and mechanisms of the gas-phase reactions of the hydroxyl radical with organic compounds under atmospheric conditions. (cdc.gov)
- As part of our ongoing program to develop efficient and robust methods for the preparation of heteroatom-containing organic compounds [25-28], we wish to report the synthesis of bis(3-methylphenyl)sulfoxide aza macrocycles derivatives (3-8) from a bis(3-methylphenyl)sulfoxide diester and an aliphathic diamine in methanol reflux with high yields (Figure 1). (samipubco.com)
- In organic chemistry, Nucleosides, Nucleotides, and Analogues are organic compounds containing a nucleobase linked to a ribose or deoxyribose sugar via a beta-glycosidic linkage. (wellnessadvocate.com)
Atoms3
- Macrocyclic compounds analogous to CROWN ETHERS but which lack any OXYGEN atoms. (uchicago.edu)
- The optical properties are compared for two boron dipyrromethene (BODIPY) dyes that differ by virtue of the substituent at the meso-site, namely, aza-N versus C-methine atoms. (ncl.ac.uk)
- In the title compound, C(31)H(39)Br(2)N(3)O(6)S(2), a 17-membered aza-macrocyclic ligand containing two ether O and three aza N atoms, the three pendant aromatic rings form an 'E' shape. (gumushane.edu.tr)
Synthesis5
- 1. Organocatalytic Synthesis of Highly Functionalized Heterocycles by Enantioselective aza-Morita-Baylis-Hillman-Type Domino Reactions. (nih.gov)
- 5. Asymmetric catalytic aza-Morita-Baylis-Hillman reaction for the synthesis of 3-substituted-3-aminooxindoles with chiral quaternary carbon centers. (nih.gov)
- 17. Activated alkene dependent one-pot, three-component aza-Morita-Baylis-Hillman reaction of ferrocenealdehyde: synthesis of highly functionalized diverse ferrocene derivatives. (nih.gov)
- In previous studies, synthesis of dibenzosulfides and dibenzosulfoxides aza macrocycles as metal cations receptors has been reported [23,24]. (samipubco.com)
- It is involved in a number of academic and industrial research programs on multistep synthesis of natural compounds and analogues with potential biological or therapeutic applications. (ic-cgo.fr)
Crown Compounds3
- Crown Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uchicago.edu)
- This graph shows the total number of publications written about "Crown Compounds" by people in this website by year, and whether "Crown Compounds" was a major or minor topic of these publications. (uchicago.edu)
- Below are the most recent publications written about "Crown Compounds" by people in Profiles. (uchicago.edu)
Heterocyclic Compounds1
- One of the most investigated types of heterocyclic compounds is decahydroacridine diones. (chemmethod.com)
Sulfur Compounds1
- It is called devil's dung because of its strong pungent smell due to the presence of sulfur compounds. (peppertrail.com)
Alcohols2
- Hydrogen bonding donors, such as alcohols, attach to the aza-N atom and promote nonradiative decay without affecting the properties of the conventional dye. (ncl.ac.uk)
- TfOH-Catalyzed Reaction of Bispropargyl Alcohols with 1,3-Dicarbonyl Compounds. (durham.ac.uk)
Molecular weight2
- Sampling results indicated that workers were exposed to polynuclear aromatic hydrocarbons in the low microgram per cubic meter range, with the light molecular weight compounds in higher concentrations than the four through seven ring compounds. (cdc.gov)
- In our body's living cells, Nucleotides (polynucleotides) & Nucleosides, and nucleic acids are complex compounds of high molecular weight. (wellnessadvocate.com)
Aromatic1
- Aromatic amines, phenolic compounds and simple aromatic solvents were occasionally present at very low levels. (cdc.gov)
Reactions4
- 2. [Development of acid-base organocatalysts for enantioselective aza-Morita-Baylis-Hillman (aza-MBH) reactions via dual activation mechanism]. (nih.gov)
- 8. Trifunctional organocatalyst-promoted counterion catalysis for fast and enantioselective aza-Morita-Baylis-Hillman reactions at ambient temperature. (nih.gov)
- 9. Enantioselective, organocatalytic Morita-Baylis-Hillman and Aza-Morita-Baylis-Hillman reactions: stereochemical issues. (nih.gov)
- 20. Palladium-Catalyzed Inverse and Normal Dehydrogenative Aza-Morita-Baylis-Hillman Reactions with γ,δ-Unsaturated Compounds. (nih.gov)
Selective1
- To address this challenge, we now present the rational, iterative development of a general reaction-based trigger utilizing 2-aza-Cope reactivity for selective and sensitive detection of FA in living systems. (nih.gov)
Lead compound2
- The academic approach employed by MLI, in conjunction with the Common Fund's Structural Biology program, allowed for the exploration of basic biological mechanisms that led to the discovery of a lead compound, the crystal structure of S1P1, and the discovery of the binding site for the compound. (nih.gov)
- A new lead compound with specific activity against renal cell carcinoma, which can be synthesized to scale for in vivo studies, and improved oral bioavailability, has been identified. (nih.gov)
Versus1
- In different organic syntheses, these nanoparticles have been mainly employed as nano-catalysts, thanks to their suitable surface area versus their corresponding compounds in bulk form [ 42 - 47 ]. (chemmethod.com)
Reaction9
- Development of a General Aza-Cope Reaction Trigger Applied to Fluorescence Imaging of Formaldehyde in Living Cells. (nih.gov)
- 3. P-chirogenic organocatalysts: application to the aza-Morita-Baylis-Hillman (aza-MBH) reaction of ketimines. (nih.gov)
- 6. An enantioselective organocatalyzed aza-Morita-Baylis-Hillman reaction of isatin-derived ketimines with acrolein. (nih.gov)
- 7. The enantioselective Morita-Baylis-Hillman reaction and its aza counterpart. (nih.gov)
- 10. Highly enantioselective aza Morita-Baylis-Hillman reaction catalyzed by bifunctional beta-isocupreidine derivatives. (nih.gov)
- 15. Chiral N-Phosphonyl Imines for an Aza-Morita-Baylis-Hillman Reaction via Group-Assisted Purification (GAP) Chemistry. (nih.gov)
- 18. New multifunctional chiral phosphines and BINOL derivatives co-catalyzed enantioselective aza-Morita-Baylis-Hillman reaction of 5,5-disubstituted cyclopent-2-enone and N-sulfonated imines. (nih.gov)
- 19. The origin of enantioselectivity in the L-threonine-derived phosphine-sulfonamide catalyzed aza-Morita-Baylis-Hillman reaction: effects of the intramolecular hydrogen bonding. (nih.gov)
- Some bis(3-methylphenyl)sulfoxide aza macrocycles (3-8) were synthesized in high yields based on the conventional methods of the reaction of corresponding bis(3-methylphenyl)sulfoxide diester and diamines in refluxing methanol. (samipubco.com)
Renal1
- Using the maternal LPD rat model, we determined renal excretion of select endogenous compounds by collecting blood and urine at various times of age. (uw.edu)
Chemical2
- Based on its experience in glycochemistry (sugar and iminosugar) the Symbiose group has proposed to develop two families of amphiphilic molecules such as galactosylsphingosine and azasugar compounds, with similar chemical characteristics compared to Edelfosine or Ohmline, that means a polar head and hydrophobic tail. (ic-cgo.fr)
- Quantum chemical calculations indicate that the electronegative aza-N atom lowers the energy of the LUMO while having little effect on the corresponding HOMO energy. (ncl.ac.uk)
Potent1
- One compound named Ohmline has been identified as a potent SK3 channel modulator. (ic-cgo.fr)
DRUGS1
- It was also prescribed as part of several compound drugs in the Hippocratic texts. (peppertrail.com)
Complex1
- Complex compounds in which a dumbbell shaped molecule is encircled by a macrocycle. (uams.edu)
THERAPEUTIC1
- ML probe #341, a compound developed by the NIH Molecular Libraries Probe Production Center at the Broad Institute of MIT and Harvard University, which is part of the NIH Common Fund Molecular Libraries Program, has been chosen for further development by The Global Health Innovative Technology (GHIT) fund as a candidate therapeutic for Chagas disease. (nih.gov)
Methods1
- Compounds, compositions containing such compounds, and methods of using such compound and compositions are described herein. (justia.com)
Biological1
- A preliminary investigation of the biological potential of this compound was conducted using a biomedically relevant target Tel26. (cnr.it)
Activity1
- Prevention of adult emerged and pupal mortality was the main activity of this compound. (who.int)
Parent1
- Parent compounds are effective in in vivo cancer models. (nih.gov)
Family2
- Macrocycles are probably the most widel y used family of host compounds in supramolecular chemistry. (samipubco.com)
- Six species in the insect resistance to neem compounds family Meliacea have been studied for pes- seems likely to be low [ 8-10 ]. (who.int)
Similar1
- Carcinogenic and related properties of compounds structurally similar to 4-methylquinoline. (nih.gov)
Presence1
- the presence of these compounds may represent a skin exposure hazard. (cdc.gov)
Effects1
- Certain compounds, like the plant alkaloid nicotine, interact with all subtypes of the nAChRs, accounting for the profound physiological effects of this compound. (justia.com)
Report1
- According to the lat- compounds have different designations, est report, it kills between 1.5-2.7 million among which azadirachtin A is the major people every year [ 1 ]. (who.int)